NOVALIQ.COM: Keyword Density Checker

Total words: 1661 | 2-word phrases: 429 | 3-word phrases: 493 | 4-word phrases: 514

PAGE INFO

Title	Try to keep the title under 60 characters (14 characters) Home - Novaliq
Description	Try to keep the meta description between 50 - 160 characters (231 characters) Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (61 characters) Revolutionize the treatment paradigm for Diabetic Retinopathy

#	Keyword	Frequency	Density
1	dry eye disease	7	1.42%
2	novel drug product	5	1.01%
3	a novel drug	3	0.61%
4	is a novel	3	0.61%
5	is the first	3	0.61%
6	eyesol® is a	3	0.61%
7	management supervisory board	2	0.41%
8	us management supervisory	2	0.41%
9	novatears®omega3 newsmedia company	2	0.41%
10	newsmedia company presentation	2	0.41%
11	novel drug category	2	0.41%
12	based on eyesol®	2	0.41%
13	new compositionofmatter ip	2	0.41%
14	with new compositionofmatter	2	0.41%
15	publications about us	2	0.41%
16	about us management	2	0.41%
17	drug category of	2	0.41%
18	we are pioneers	2	0.41%
19	supervisory board our	2	0.41%
20	disease read more	2	0.41%
21	dry eye drug	2	0.41%
22	contact novaliq in	2	0.41%
23	novaliq in usa	2	0.41%
24	in usa careers	2	0.41%
25	usa careers investor	2	0.41%
26	careers investor relation	2	0.41%
27	novel drug products	2	0.41%
28	treatment paradigm for	2	0.41%
29	paradigm for diabetic	2	0.41%
30	for diabetic retinopathy	2	0.41%

#	Keyword	Frequency	Density
1	is a novel drug	3	0.58%
2	eyesol® is a novel	3	0.58%
3	treatment paradigm for diabetic	2	0.39%
4	eye disease read more	2	0.39%
5	novel drug category of	2	0.39%
6	nov03 perfluorohexyloctane btq 1902	2	0.39%
7	perfluorohexyloctane btq 1902 novatears®	2	0.39%
8	a novel drug category	2	0.39%
9	dry eye disease read	2	0.39%
10	publications about us management	2	0.39%
11	disease glaucoma dermatology diabetic	2	0.39%
12	about us management supervisory	2	0.39%
13	us management supervisory board	2	0.39%
14	management supervisory board our	2	0.39%
15	contact novaliq in usa	2	0.39%
16	novaliq in usa careers	2	0.39%
17	in usa careers investor	2	0.39%
18	usa careers investor relation	2	0.39%
19	paradigm for diabetic retinopathy	2	0.39%
20	glaucoma dermatology diabetic retinopathy	2	0.39%
21	novatears®omega3 newsmedia company presentation	2	0.39%
22	dry eye disease glaucoma	2	0.39%
23	with new compositionofmatter ip	2	0.39%
24	limitations in eye care	2	0.39%
25	overcoming limitations in eye	2	0.39%
26	technology eyesol® novel drug	2	0.39%
27	eyesol® novel drug product	2	0.39%
28	manufacturing control cmc disease	2	0.39%
29	control cmc disease areaspipeline	2	0.39%
30	in eye care therapies	2	0.39%
31	developed for the treatment	1	0.19%
32	since 2013 and successfully	1	0.19%
33	is the first waterfree	1	0.19%
34	the first waterfree eye	1	0.19%
35	first waterfree eye drop	1	0.19%
36	waterfree eye drop based	1	0.19%
37	product candidates our latestage	1	0.19%
38	2013 and successfully commercialized	1	0.19%
39	novatears® is ce certified	1	0.19%
40	drop based on eyesol®	1	0.19%

#	URL	Whois	Check
1	https://dermaliq.com/	Whois	dermaliq.com
2	http://www.betaliq.com/	Whois	betaliq.com
3	https://dermaliq.com/	Whois	dermaliq.com
4	http://www.betaliq.com/	Whois	betaliq.com
5	https://www.formativ.net/	Whois	formativ.net